News | RIVM

Update on RIVM report “Silicone breast implants in the Netherlands”, State of Affairs October 2017

In June 2016, RIVM published the results of a study on breast implants in the Netherlands.

RIVM to contribute to new Horizon2020 project on oceans and human health across Europe

A new EU Horizon2020 project Seas, Oceans and Public Health in Europe (SOPHIE) will explore the complex interplay between the health of the marine environment and that of humans.

Dutch collaboration in One Health European Joint Programme (EJP)

RIVM, Wageningen Bioveterinary Research (WBVR) and the Netherlands Centre for One Health (NCOH) are involved in a recently granted One Health European Joint Programme which will start in January 20

Survey health complaints of women with a silicone breast implant

This report provides a broad overview of the health complaints experienced by women with silicone breast implants in the Netherlands.

Efficiency and transparency of clinical drug trials must improve

The efficiency and transparency of clinical drug trials in the Netherlands must improve. That concludes Sander van den Bogert in his PhD thesis ‘Trials & Tribulations.

Benefits and bottlenecks for early marketing authorisation of new medicines

Patients are asking increasingly often for quicker access to new, innovative medicines. This requires a more effective use of flexible marketing authorisation procedures.

Particle contamination on Silimed breast implants poses minimal risk

Particles were found on Silimed silicone-based breast implants that should not be there. These included man-made mineral fibres, such as glasswool and rockwool.

European Baseline Report SUSTAIN

The SUSTAIN project has published the European baseline report titled ‘Integrated care for older people living at home – Current situation and ambition of sites participating in the SUSTAIN project

EFSA agrees with RIVM that potential effect of BPA on the immune system requires further attention

RIVM expressed concerns on the effects of bisphenol a (BPA) on the immune system in a report issued in March 2016.

RIVM research basis for historic climate agreement on HFCs

Scientific research by RIVM’s Guus Velders stood partly at the basis of the HFC global climate agreement.